PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New study alters long-held beliefs about shingles

2011-02-02
(Press-News.org) ROCHESTER, Minn. -- For decades, medical wisdom about shingles has been that it's a once-in-a-lifetime experience. The commonly-held belief is that patients are protected from a recurrence of the herpes zoster virus, which causes shingles, after one episode. But according to a study published in the February issue of Mayo Clinic Proceedings, recurrences of shingles may be significantly more common than doctors have suspected.

"It's been thought that recurrences were limited to people with compromised immune systems, for instance from chemotherapy or bloodborne malignancies, but this is not the case," says lead author Barbara Yawn, M.D., director of research at Olmsted Medical Center in Rochester. "Recurrence was prevalent in the immunocompetent population. We were very surprised by the results."

The research team examined medical records, dating from 1996 to 2001, of nearly 1,700 patients over age 22 who had a documented episode of shingles. The condition causes a specific type of skin rash and severe pain. They then searched area medical records to determine whether those patients had been treated for a second episode at any point, following them up to 12 years (the average follow-up was eight years). The data showed the recurrence rate was over 5 percent, the same rate an age-matched cohort would be expected to experience a first case of shingles. Some patients had experienced as many as three recurrences. "And that's only within eight years," Dr. Yawn notes. "As you continue to follow these patients throughout their lives, it's likely the recurrence rate will be much higher than 5 percent."

The study found that women, who are more likely than men to have shingles, also were more likely to experience a recurrence of the disease. Although the team had suspected that recurrence rates would be higher in older patients, age did not appear to make individuals more susceptible to another round of the disease. Instead, researchers found the most striking determinant for recurrence was patients' pain during the initial episode. Those who had experienced pain lasting more than 30 days after the initial onset of shingles were more likely to face a recurrence, particularly in the first three to four years after the initial episode. This, too, surprised the research team. "We'd thought that suffering a worse case would possibly give patients more resistance to a second occurrence, but our data presented the exact opposite," says Dr. Yawn.

The results suggest that the herpes zoster vaccine, which is known to reduce first-time occurrences of shingles by 50 percent, may help patients avoid a second episode. "Until now, we haven't been able to tell patients their risks of getting zoster a second time," Dr. Yawn says. "This study offers another piece of information for patients and doctors who are discussing the likelihood of recurrence and considering a prevention strategy."

###

A peer-reviewed journal, Mayo Clinic Proceedings publishes original articles and reviews dealing with clinical and laboratory medicine, clinical research, basic science research and clinical epidemiology. Mayo Clinic Proceedings is published monthly by Mayo Foundation for Medical Education and Research as part of its commitment to the medical education of physicians. The journal has been published for more than 80 years and has a circulation of 130,000 nationally and internationally. Articles are available online at www.mayoclinicproceedings.com.

About Mayo Clinic

Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit www.mayoclinic.org/about/ and www.mayoclinic.org/news.

END



ELSE PRESS RELEASES FROM THIS DATE:

High Arctic avian athlete gives lessons about animal welfare

2011-02-02
Researchers report that an arctic relative of the grouse has evolved to cope with its extreme environment by moving efficiently at high speeds or when carrying winter weight. This discovery is of relevance to welfare in the poultry industry where birds are bred to be heavier. Ultimately better understanding the physiology of a natural animal model of extreme weight gain could one day lead to improving the welfare and meat yield of domesticated breeds and so contribute to preventing a future food security crisis. The Biotechnology and Biological Sciences Research Council ...

Cluster encounters a natural particle accelerator

Cluster encounters a natural particle accelerator
2011-02-02
ESA's Cluster satellites have flown through a natural particle accelerator just above Earth's atmosphere. The data they collected are unlocking how most of the dramatic displays of the northern and southern lights are generated. Two of Cluster's four satellites found themselves in a natural particle accelerator above the northern hemisphere on 5 June 2009. The first to cross was satellite C3 at an altitude of 6400 km, followed five minutes later by C1 at 9000 km. This is the first time that scientists have measured such a region simultaneously using more than one satellite. ...

Study links physical activity to political participation

2011-02-02
How is going for a jog like voting for president? As far as our brains are concerned, physical activity and political activity are two sides of the same coin. Scientists found that people who live in more active states are also more likely to vote. And in an experiment, volunteers who were exposed to active words like "go" and "move" said they were more likely to vote than did people who saw words like "relax" and "stop." The study was inspired by research showing that brains lump all kinds of activity together. For instance, a message that's meant to promote fitness—physical ...

Researchers unlock the potential for exploring kidney regeneration

2011-02-02
Boston, MA - It is estimated that up to 10 percent of the U.S. population may have some form of renal disease, with 450,000 patients with end stage renal disease (ESRD) requiring hemodialysis. Researchers at Brigham and Women's Hospital, Massachusetts General Hospital and the University of Pittsburgh have identified a cell in zebrafish that can be transplanted from one fish to another to regenerate nephrons, providing the potential to improve kidney function. These findings are published in the February 3 edition of Nature. Currently, the five-year survival rate for ...

Where has all the Gulf spill oil gone?

Where has all the Gulf spill oil gone?
2011-02-02
New Rochelle, NY, February 1, 2011—Many questions remain about the fate and environmental impact of the marine oil caused by the massive spill in the Gulf of Mexico from the Deepwater Horizon offshore drilling platform. A predictive model based on engineering design tools is described in an article in Environmental Engineering Science, a peer-reviewed journal published by Mary Ann Liebert, Inc. www.liebertpub.com). The article is available free online at www.liebertpub.com/ees Unlike more common surface spills, the Deepwater Horizon incident was the first spill to release ...

Brain scans predict likely success when it comes to quitting smoking

2011-02-02
New research from University of Michigan says brain scans showing neural reactions can predict behavior change even better than the person whose brain is being scanned. Emily Falk, director of University of Michigan's Communication Neuroscience Laboratory, recently led a study that scanned the brain activity of 28 heavy smokers to investigate whether pro-health messages would have an impact on their ability to quit smoking. The smokers were recruited from an anti-smoking program. The researchers found a positive relationship exists between observed brain activity and ...

Therapeutic AIDS vaccine designed by HIVACAT reduces the viral load in the majority of AIDS patients

2011-02-02
The therapeutic vaccines are a priority research line of the HIVACAT, the catalan programme for the development of therapeutic vaccines and prevention against the Human Immunodeficiency Virus (HIV). This type of therapeutic vaccine helps the patients who are carriers of the virus, combat infection and control the appearance of AIDS in the same way as with the current antiretroviral treatments. The final aim of the therapeutic vaccines will be to avoid a life long treatment with antiretroviral drugs. The research team 'Infectious Diseases and AIDS' led by Dr. Josep Maria ...

Technology protects cotton from caterpillar's appetite

Technology protects cotton from caterpillars appetite
2011-02-02
BLACKVILLE, S.C. — The furry-looking insects start their development smaller than the head of a pin, but the caterpillars soon develop an appetite for cotton as big as the crop. To demonstrate the insects' destructive power, Clemson University entomologist Jeremy Greene planted two cotton varieties — one genetically modified to provide protection from caterpillars, one not — in a demonstration field at the Edisto Research and Education Center. The non-protected cotton was planted in a pattern that spelled the word "Tigers." Aerial photographs taken near harvest show ...

PET scans may allow early prediction of response to targeted therapy of thyroid cancer

2011-02-02
Reston, Va. (February 1, 2011) — Positron emission tomography (PET) can image metabolic changes following treatment with the protein kinase inhibitor vandetanib, helping to define the therapy response or the effectiveness of the therapeutic agent, according to research published in the February issue of The Journal of Nuclear Medicine. Currently being tested in clinical trials, vandetanib inhibits the function of the RET (rearranged-during-transfection protein) proto-oncogene and other protein kinases involved in the development and progression of cancer. "For the most ...

Barrow TRPV1 research highlighted in Journal of Neuroscience

2011-02-02
(Phoenix, Arizona February 1, 2011) -- Research by a Barrow Neurological Institute scientist on the thermoregulatory effects of a receptor more commonly studied for its role in pain is the cover story in the Feb. 2 issue of the Journal of Neuroscience. The research was conducted by an international team led by Andrej Romanovsky, MD, PhD, Director of the Systemic Inflammation Laboratory (FeverLab), at Barrow, which is a part of St. Joseph's Hospital and Medical Center. The featured research discovers a new role of TRPV1 (transient receptor potential vanilloid-1) receptors ...

LAST 30 PRESS RELEASES:

New route to ‘quantum spin liquid’ materials discovered for first time

Chang’e-6 basalts offer insights on lunar farside volcanism

Chang’e-6 lunar samples reveal 2.83-billion-year-old basalt with depleted mantle source

Zinc deficiency promotes Acinetobacter lung infection: study

How optogenetics can put the brakes on epilepsy seizures

Children exposed to antiseizure meds during pregnancy face neurodevelopmental risks, Drexel study finds

Adding immunotherapy to neoadjuvant chemoradiation may improve outcomes in esophageal cancer

Scientists transform blood into regenerative materials, paving the way for personalized, blood-based, 3D-printed implants

Maarja Öpik to take up the position of New Phytologist Editor-in-Chief from January 2025

Mountain lions coexist with outdoor recreationists by taking the night shift

Students who use dating apps take more risks with their sexual health

Breakthrough idea for CCU technology commercialization from 'carbon cycle of the earth'

Keck Hospital of USC earns an ‘A’ Hospital Safety Grade from The Leapfrog Group

Depression research pioneer Dr. Philip Gold maps disease's full-body impact

Rapid growth of global wildland-urban interface associated with wildfire risk, study shows

Generation of rat offspring from ovarian oocytes by Cross-species transplantation

Duke-NUS scientists develop novel plug-and-play test to evaluate T cell immunotherapy effectiveness

Compound metalens achieves distortion-free imaging with wide field of view

Age on the molecular level: showing changes through proteins

Label distribution similarity-based noise correction for crowdsourcing

The Lancet: Without immediate action nearly 260 million people in the USA predicted to have overweight or obesity by 2050

Diabetes medication may be effective in helping people drink less alcohol

US over 40s could live extra 5 years if they were all as active as top 25% of population

Limit hospital emissions by using short AI prompts - study

UT Health San Antonio ranks at the top 5% globally among universities for clinical medicine research

Fayetteville police positive about partnership with social workers

Optical biosensor rapidly detects monkeypox virus

New drug targets for Alzheimer’s identified from cerebrospinal fluid

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring, treatment

Argonne to explore novel ways to fight cancer and transform vaccine discovery with over $21 million from ARPA-H

[Press-News.org] New study alters long-held beliefs about shingles